Healthcare technology leader sets ambitious targets for patient reach and environmental impact while achieving workforce diversity milestone ahead of schedule.
The first comprehensive US diagnostic guidelines in two decades establish standardised evaluation process across primary and specialty care settings, emphasising a patient-centred approach and integration of emerging biomarkers.
New research from CUNY identifies how brain immune cells drive neurodegeneration through stress-induced toxic lipid production, offering potential therapeutic targets.
New research suggests that reducing mandatory hand hygiene observations from 200 to 50 per unit monthly would maintain data quality while freeing resources for targeted infection prevention initiatives.
A European research initiative has made significant progress in identifying new treatments to protect heart muscle during acute cardiac events, with potential implications for both diabetic and non-diabetic patients.
UCLA Health study demonstrates significant impact of genetic diagnostics on treatment decisions and specialist referrals in complex neurodevelopmental cases, pointing towards more personalised medical approaches.
New research from the University of Nottingham demonstrates significant psychological and physiological impacts of digital technology intensity in modern workplaces, with implications for occupational health.
Early-onset colorectal cancer incidence rates are increasing in more than half of the countries studied worldwide, with the steepest rises seen in New Zealand, Chile, and Puerto Rico, according to comprehensive new research published in The Lancet Oncology [1].
A groundbreaking RNA-based technology allows therapeutic genes that are too large for conventional delivery methods to be successfully transported into cells, offering new hope for treating muscular dystrophies and other genetic disorders caused by mutations in large genes.
South Korean researchers have developed a soft, adhesive brain sensor that could significantly improve the effectiveness of ultrasound-based epilepsy treatments by enabling accurate, real-time monitoring of brain activity during stimulation.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Anna Flury